Skip to main content
SpringerLink
Log in

Psychosoziale Aspekte von Harnblasenkarzinompatienten

Psychosocial aspects of patients with bladder cancer

  • Psychoonkologie
  • Published:
Der Onkologe Aims and scope

Zusammenfassung

Tumorpatienten müssen sich mit dem Gefühl der Unsicherheit hinsichtlich des weiteren Lebens und Krankheitsverlaufs sowie mit unerwünschten Nebenwirkungen der Therapie auseinandersetzen. Niedrige Lebensqualität ist bei krebskranken Patienten ein unabhängiger prognostischer Faktor für geringere Überlebensraten. Psychosozialer Stress beeinflusst negativ das Immunsystem (Reduktion der NK-Zellen, Anstieg des Cortisolspiegels). Trotz verbesserter Diagnostik und Therapie bleibt das Blasenkarzinom durch hohe Rezidiv- und Progressionshäufigkeit gekennzeichnet. Für die Behandlung eines Harnblasentumors werden, je nach Tumorstadium, verschiedene therapeutische Maßnahmen empfohlen, die sich auf die Lebensqualität auswirken können. Studien über die psychosozialen Bedürfnisse von Patienten mit Harnblasenkarzinom sind vergleichsweise selten.

Abstract

Cancer patients have to deal with the feeling of insecurity regarding the future life and disease progression and also with undesirable side effects of treatment. Stress-related psychosocial factors in patients with cancer are an independent prognostic factor for low survival and major cancer-related mortality. Psychosocial stress negatively affects the immune system, e.g. reduction of natural killer (NK) cells and increase in cortisol levels. Despite improved diagnostics and therapy, bladder carcinoma (BC) remains characterized by high recurrence and progression rates. For the treatment of a urinary bladder tumor, various therapeutic measures are recommended depending on the tumor stage, which can have a different effect on the quality of life. Studies on the psychosocial care needs of patients with bladder cancer are comparatively rare.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Robert-Koch-Institut (2016) Bericht zum Krebsgeschehen in Deutschland 2016

    Google Scholar 

  2. AWMF, Deutsche Krebsgesellschaft e. V., Deutsche Krebshilfe (Hrsg) (2016) Leitlinienprogramm Onkologie S3-Leitlinie Früherkennung, Diagnose, Therapie und Nachsorge des Harnblasenkarzinoms – Konsultationsfassung

    Google Scholar 

  3. Babjuk M, Böhle A, Burger M et al (2016) EAU guidelines on non-muscle-invasive bladder cancer (Ta, T1 and CIS)

    Google Scholar 

  4. Witjes JA, Comperat E, Cowan NC et al (2016) EAU guidelines on muscle-invasive and metastatic bladder cancer

    Google Scholar 

  5. Singer S, Ziegler C, Schwalenberg T et al (2013) Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer. Support Care Cancer 21(5):1383–1393

    Article  CAS  PubMed  Google Scholar 

  6. Sylvester RJ, van der Meijden AP, Oosterlinck W et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49(3):466–465 (discussion 475–467)

    Article  PubMed  Google Scholar 

  7. Schmidt S, Frances A, Lorente Garin JA et al (2015) Quality of life in patients with non-muscle-invasive bladder cancer: one-year results of a multicentre prospective cohort study. Urol Oncol 33(1):19.e7–19.e15

    Article  Google Scholar 

  8. Blazeby JM, Hall E, Aaronson NK et al (2014) Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer. Eur Urol 66(6):1148–1156

    Article  PubMed  PubMed Central  Google Scholar 

  9. Cody JD, Nabi G, Dublin N et al (2012) Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003306.pub2

    Google Scholar 

  10. Hautmann RE, Abol-Enein H, Davidsson T et al (2013) ICUD-EAU International Consultation on Bladder Cancer 2012: urinary diversion. Eur Urol 63(1):67–80

    Article  PubMed  Google Scholar 

  11. Yokomizo A, Kanimoto Y, Okamura T et al (2016) Randomized controlled study of the efficacy, safety and quality of life with low dose bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer. J Urol 195(1):41–46

    Article  PubMed  Google Scholar 

  12. Hautmann S, Hautmann R (2010) Harnblasenkarzinom. In: Hautmann R (Hrsg.) Urologie. Springer, Heidelberg, S 212 ff

    Chapter  Google Scholar 

  13. Hegele A, Skrobek L (2016) Urologie. Essentials. Intensivkurs zur Weiterbildung, 1. Aufl. Springer, Heidelberg

    Google Scholar 

  14. Schmelz HU, Sparwasser C, Weidner W (2014) Facharztwissen Urologie, 4. Aufl. Springer, Heidelberg

    Google Scholar 

  15. Hedgepeth RC, Gilbert SM, He C et al (2010) Body image and bladder cancer specific quality of life in patients with ileal conduit and neobladder urinary diversions. Urology 76(3):671–675

    Article  PubMed  Google Scholar 

  16. Tejido-Sánchez A, García-González L, Jiménez-Alcaide E et al (2014) Quality of life in patients with ileal conduit cystectomy due to bladder cancer. Actas Urol Esp 38(2):90–95

    Article  PubMed  Google Scholar 

  17. Imbimbo C, Mirone V, Siracusano S et al (2015) Quality of life assessment with orthotopic ileal neobladder reconstruction after radical cystectomy: results from a prospective Italian multicenter observational study. Urology 86(5):974–979

    Article  PubMed  Google Scholar 

  18. Ali AS, Hayes MC, Birch B et al (2015) Health related quality of life (HRQoL) after cystectomy: comparison between orthotopic neobladder and ileal conduit diversion. Eur J Surg Oncol 41(3):295–299

    Article  CAS  PubMed  Google Scholar 

  19. Gerharz EW, Månsson A, Hunt S et al (2005) Quality of life after cystectomy and urinary diversion: an evidence based analysis. J Urol 174(5):1729–1736

    Article  PubMed  Google Scholar 

  20. James AC, Lin DW, Wright JL (2014) Neobladders and continent catheterizable stomas for the bladder cancer survivor. Curr Opin Urol 24(4):407–414

    Article  PubMed  Google Scholar 

  21. Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF (Hrsg) (2016) Leitlinienprogramm Onkologie: S3-Leitlinie Früherkennung, Diagnose, Therapie und Nachsorge des Harnblasenkarzinoms, Langversion 1.1. http://leitlinienprogramm-onkologie.de/Harnblasenkarzinom.92.0.html. Zugegriffen: 25.05.2017

    Google Scholar 

  22. Sternberg CN, Yagoda A, Scher HI et al (1989) Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 64(12):2448–2458

    Article  CAS  PubMed  Google Scholar 

  23. Shi Q, Smith TG, Michonski JD et al (2011) Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society’s Studies of Cancer Survivors. Cancer 117(12):2779–2790

    Article  PubMed  PubMed Central  Google Scholar 

  24. Scott JA, Lasch KE, Barsevick AM, Piault-Louis E (2011) Patients’ experiences with cancer-related fatigue: a review and synthesis of qualitative research. Oncol Nurs Forum 38(3):E191–203

    Article  PubMed  Google Scholar 

  25. Montazeri A (2009) Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes 2009(7):102

    Article  Google Scholar 

  26. Singer S, Kuhnt S, Zwerenz R et al (2011) Age- and sex-standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients. Br J Cancer 105(3):445–451

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Ficarra V, Righetti R, D’Amico A et al (2000) General state of health and psychologicalwell-being in patients after surgery for urological malignant neoplasms. Urol Int 65:130–134

    Article  CAS  PubMed  Google Scholar 

  28. Henningsohn L, Wijkström H, Pedersen J et al (2003) Time after surgery, symptoms and well-being in survivors of urinary bladder cancer. BJU Int 91:325–330

    Article  CAS  PubMed  Google Scholar 

  29. Yang YL, Liu L, Li MY et al (2016) Psychological disorders and psychosocial resources of patients with newly diagnosed bladder and kidney cancer: a cross-sectional study. PLoS ONE 11(5):e155607

    Article  PubMed  PubMed Central  Google Scholar 

  30. Palapattu GS, Haisfield-Wolfe ME, Walker JM, Brintzenhofen-Szoc K, Trock B, Zabora J, Schoenberg M (2004) Assessment of perioperative psychological distress in patients undergoing radical cystectomy for bladder cancer. J Urol 172(5 Pt 1):1814–1817

    Article  PubMed  Google Scholar 

  31. Gacci M, Saleh O, Cai T et al (2013) Quality of life in women undergoing urinary diversion for bladder cancer: results of a multicenter study among long-term disease-free survivors. Health Qual Life Outcomes 11:43

    Article  PubMed  PubMed Central  Google Scholar 

  32. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMT) (2014) Psychoonkologische Diagnostik, Beratung und Behandlung von erwachsenen Krebspatienten, Langversion 1.1, AWMT-Registernummer 032/051 OL. http://leitlinienprogramm-onkologie.de/Leitlinien.7.0.html (Stand 25.05.2017)

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Urologie, Universitätsmedizin Rostock, Ernst-Heydemann-Str. 6, 18057, Rostock, Deutschland

    D. L. Dräger, M. M. Müller, T. Johnscher, B. Kunz, K. D. Sievert & O. W. Hakenberg

Authors
  1. D. L. Dräger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. M. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Johnscher
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Kunz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. D. Sievert
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. O. W. Hakenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. L. Dräger.

Ethics declarations

Interessenkonflikt

D. L. Dräger, M. M. Müller, T. Johnscher, B. Kunz, K. D. Sievert und O.W. Hakenberg geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dräger, D.L., Müller, M.M., Johnscher, T. et al. Psychosoziale Aspekte von Harnblasenkarzinompatienten. Onkologe 24, 64–68 (2018). https://doi.org/10.1007/s00761-017-0323-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-017-0323-6

Schlüsselwörter

Keywords

Search

Navigation